Pharmacokinetics of Miltefosine in Children and Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

December 31, 2015

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

Miltefosine

Children (2-12 years of age) and adults (18-60 years of age) will receive Miltefosine PO at a dose of 1.8-2.5 mg/kg/day for 28 days.

Trial Locations (1)

5930

Corporación Centro Internacional de entrenamiento e Investigaciónes Médicas, Santiago de Cali

All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

Centro Internacional de Entrenamiento e Investigaciones Médicas

OTHER

NCT01462500 - Pharmacokinetics of Miltefosine in Children and Adults | Biotech Hunter | Biotech Hunter